Bill
Bill > SCR100
HI SCR100
HI SCR100Requesting The Department Of Health To Convene A Therapeutic Psilocybin Working Group To Examine The Medicinal And Therapeutic Effects Of Psilocybin And Develop A Long-term Strategic Plan, Should Food And Drug Administration Approval For Medical Use Be Obtained, To Enable The Availability Of Therapeutic Psilocybin Or Psilocybin-based Products That Are Safe, Accessible, And Affordable For Adults Twenty-one Years Of Age Or Older.
summary
Introduced
03/11/2022
03/11/2022
In Committee
04/19/2022
04/19/2022
Crossed Over
03/31/2022
03/31/2022
Passed
Dead
05/05/2022
05/05/2022
Introduced Session
2021 Regular Session
Bill Summary
RESOLUTION REQUESTING THE DEPARTMENT OF HEALTH TO CONVENE A THERAPEUTIC PSILOCYBIN WORKING GROUP TO EXAMINE THE MEDICINAL AND THERAPEUTIC EFFECTS OF PSILOCYBIN AND DEVELOP A LONGTERM STRATEGIC PLAN, should food and Drug Administration approval for medical use be obtained, TO enable the availability of therapeutic psilocybin or psilocybin-based products that are safe, accessible, and affordable for adults twenty-one years of age or older. .
Committee Categories
Budget and Finance, Business and Industry, Education, Health and Social Services
Sponsors (10)
Stanley Chang (D)*,
Jarrett Keohokalole (D)*,
Michelle Kidani (D)*,
Chris Lee (D)*,
Bennette Misalucha (D)*,
Mike Gabbard (D),
Gilbert Keith-Agaran (D),
Clarence Nishihara (D),
Joy San Buenaventura (D),
Maile Shimabukuro (D),
Last Action
Report adopted; referred to the committee(s) on CPC with Representative(s) Branco voting aye with reservations; none voting no (0) and Representative(s) Hashimoto, McKelvey, Ward excused (3). (on 04/19/2022)
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
Loading...